GB9715584D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9715584D0
GB9715584D0 GBGB9715584.0A GB9715584A GB9715584D0 GB 9715584 D0 GB9715584 D0 GB 9715584D0 GB 9715584 A GB9715584 A GB 9715584A GB 9715584 D0 GB9715584 D0 GB 9715584D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9715584.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to GBGB9715584.0A priority Critical patent/GB9715584D0/en
Publication of GB9715584D0 publication Critical patent/GB9715584D0/en
Application status is Pending legal-status Critical

Links

GBGB9715584.0A 1997-07-23 1997-07-23 Compounds Pending GB9715584D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9715584.0A GB9715584D0 (en) 1997-07-23 1997-07-23 Compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9715584.0A GB9715584D0 (en) 1997-07-23 1997-07-23 Compounds
JP24100498A JP3987645B2 (en) 1997-07-23 1998-07-23 Their use as nicotinamide derivatives and pharmaceutical
GB9816099A GB2327675B (en) 1997-07-23 1998-07-23 Nicotinamide derivatives and their use as medicaments

Publications (1)

Publication Number Publication Date
GB9715584D0 true GB9715584D0 (en) 1997-10-01

Family

ID=10816363

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9715584.0A Pending GB9715584D0 (en) 1997-07-23 1997-07-23 Compounds
GB9816099A Expired - Fee Related GB2327675B (en) 1997-07-23 1998-07-23 Nicotinamide derivatives and their use as medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9816099A Expired - Fee Related GB2327675B (en) 1997-07-23 1998-07-23 Nicotinamide derivatives and their use as medicaments

Country Status (2)

Country Link
JP (1) JP3987645B2 (en)
GB (2) GB9715584D0 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2436544A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes
OA12540A (en) 2001-01-31 2006-06-05 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes.
JP2004518691A (en) 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク Valid thiazolyl as inhibitors of Pde4 isozyme -, oxazolyl -, pyrrolyl -, imidazolyl - acid amide derivative
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US20040067985A1 (en) * 2002-10-04 2004-04-08 Fortuna Haviv Method of inhibiting angiogenesis
GB0317472D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Nicotinamide derivatives useful as PDE4 inhibitors
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
US8597947B2 (en) 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
JPWO2008026687A1 (en) 2006-09-01 2010-01-21 杏林製薬株式会社 Pyrazolopyridine carboxamide derivatives and phosphodiesterase containing them (pde) inhibitors
EP2147094B2 (en) 2007-04-18 2018-02-21 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
ES2552733T3 (en) 2007-11-16 2015-12-01 Rigel Pharmaceuticals, Inc. Carboxamide compounds, and amine sulfonamide for metabolic disorders
ES2553340T3 (en) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Carboxamide compounds, and amine sulfonamide for metabolic disorders
FR2926297B1 (en) 2008-01-10 2013-03-08 Centre Nat Rech Scient inhibitory chemical molecules of the mechanism of splicing for treating diseases resulting from splicing of anomalies.
ES2552549T3 (en) 2008-04-23 2015-11-30 Rigel Pharmaceuticals, Inc. Carboxamide compounds for treating metabolic disorders
EP2505198A1 (en) 2011-04-01 2012-10-03 Société Splicos Compounds for use as therapeutic agents affecting p53 expression and/or activity
KR101412794B1 (en) * 2011-07-27 2014-07-01 보령제약 주식회사 New compound, the preparation thereof and the pharmaceutical composition comprising the same for anti-angiogenic drug
US20180016553A1 (en) 2014-12-30 2018-01-18 Cell Cure Neurosciences Ltd. Rpe cell populations and methods of generating same
WO2016108240A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Assessing retinal pigment epithelial cell populations
EP3328995A1 (en) 2015-07-29 2018-06-06 Hadasit Medical Research Services And Development Large scale production of retinal pigment epithelial cells
EP3331995A1 (en) 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
CA2993912A1 (en) 2015-08-05 2017-02-09 Cell Cure Neurosciences Ltd. Preparation of retinal pigment epithelium cells
CN108699525A (en) 2015-10-26 2018-10-23 细胞治疗神经科学有限公司 Preparation of retinal pigment epithelium cells
WO2018170494A1 (en) 2017-03-16 2018-09-20 Bio Time, Inc. Methods for measuring therapeutic effects of retinal disease therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS612667B2 (en) * 1973-11-20 1986-01-27 Hisamitsu Pharmaceutical Co
JPH01113369A (en) * 1987-10-23 1989-05-02 Mitsubishi Petrochem Co Ltd Nicotinic acid amide compound
US4861891A (en) * 1988-08-31 1989-08-29 Pfizer Inc. Antidepressant N-substituted nicotinamide compounds
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases

Also Published As

Publication number Publication date
GB2327675A (en) 1999-02-03
JPH11147874A (en) 1999-06-02
GB2327675A8 (en) 1999-02-25
JP3987645B2 (en) 2007-10-10
GB9816099D0 (en) 1998-09-23
GB2327675B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
EG24177A (en) Novel compounds
GB9701684D0 (en) Novel compounds
PL341824A1 (en) Aryl-condensed azapolycyclic compounds
GB9722520D0 (en) Compounds
GB9714102D0 (en) Compounds
CZ9904201A3 (en) Novel compounds
GB9706255D0 (en) Novel compounds
ZA9805323B (en) New compounds
GB9715584D0 (en) Compounds
SG65762A1 (en) Triazinylaminostilbene compounds
CZ9903551A3 (en) Compounds
HK1027961A1 (en) Benzocycloheptathiophene compounds
HRP20000508A2 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
GB9726365D0 (en) Compounds
PL335699A1 (en) Tetrahydropyridic compounds
ZA9805329B (en) Compounds
PL336996A1 (en) Guanidilating compounds
EP1000071A4 (en) Neurologically-active compounds
GB9708694D0 (en) Compounds
GB9709303D0 (en) Compounds
ZA9803736B (en) New compounds
GB9708805D0 (en) Compounds
ZA9809839B (en) New spirocyciic compounds
IL132677D0 (en) Compounds